Peters S, Piha-Paul SA, Sehgal K, Calvo E, et al. First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer. J Clin Oncol 2026 Apr 20:JCO2502016. doi: 10.1200/JCO-25-02016.
PMID: 42008777